The company was priced as if it was going oob. Now they have the cash to move foward. The cash will be used for repurchase and ESS plus restriction on selling. Nice late Friday PR. I'd hate to be short coming Monday morning as we'll get back to the true value of the pipeline.

$3M plus over $5M of warrants. = $8M.

Quote:

---

It is expected that the net proceeds will be used to repurchase part of the Series H Preferred from the Company's two largest institutional investors, for preparations towards the initiation of the Phase 2 clinical study of Engineered Skin Substitute (ESS) for the treatment of severe burns in collaboration with the US Army, and for general working capital purposes. The largest holders of the Series H Convertible Preferred Stock agreed to certain trading restrictions as part of the transaction.

---

http://ir.amarantus.com/press-releases/detail...l-infusion

[Edit] Looks like I got one thumbs down from a short already. Uh-Oh. Gap up on Monday!